Altimmune Inc (ALT)
8.455
-1.06
(-11.19%)
USD |
NASDAQ |
Nov 14, 16:00
8.35
-0.10
(-1.24%)
Pre-Market: 09:23
Altimmune Free Cash Flow (Quarterly): -18.11M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.11M |
| March 31, 2024 | -16.36M |
| December 31, 2023 | -16.53M |
| September 30, 2023 | -20.49M |
| June 30, 2023 | -19.38M |
| March 31, 2023 | -19.46M |
| December 31, 2022 | -17.34M |
| September 30, 2022 | -15.11M |
| June 30, 2022 | -16.72M |
| March 31, 2022 | -13.54M |
| December 31, 2021 | -22.12M |
| September 30, 2021 | -17.89M |
| June 30, 2021 | -26.70M |
| March 31, 2021 | -23.84M |
| December 31, 2020 | -13.43M |
| September 30, 2020 | -9.584M |
| June 30, 2020 | -7.253M |
| March 31, 2020 | -4.385M |
| December 31, 2019 | -2.004M |
| September 30, 2019 | -2.436M |
| June 30, 2019 | -3.073M |
| March 31, 2019 | -2.117M |
| December 31, 2018 | -5.164M |
| September 30, 2018 | -1.191M |
| June 30, 2018 | 0.1765M |
| Date | Value |
|---|---|
| March 31, 2018 | -4.226M |
| December 31, 2017 | -4.835M |
| September 30, 2017 | -4.282M |
| June 30, 2017 | -7.864M |
| March 31, 2017 | -3.400M |
| December 31, 2016 | -1.534M |
| September 30, 2016 | -2.013M |
| June 30, 2016 | -1.671M |
| March 31, 2016 | -1.355M |
| December 31, 2015 | -1.847M |
| September 30, 2015 | -1.339M |
| June 30, 2015 | 2.632M |
| March 31, 2015 | -2.749M |
| December 31, 2014 | -3.522M |
| September 30, 2014 | -2.137M |
| June 30, 2014 | -0.5755M |
| March 31, 2014 | -2.331M |
| December 31, 2013 | -6.256M |
| September 30, 2013 | -0.6907M |
| June 30, 2013 | -0.5405M |
| March 31, 2013 | 0.2349M |
| December 31, 2012 | -2.145M |
| September 30, 2012 | 1.734M |
| June 30, 2012 | -2.704M |
| March 31, 2012 | 0.7914M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-26.70M
Minimum
Jun 2021
-2.004M
Maximum
Dec 2019
-15.80M
Average
-16.72M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | -458.90M |
| Viking Therapeutics Inc | -21.96M |
| Amgen Inc | 3.314B |
| Avid Bioservices Inc | -4.991M |
| NovaBay Pharmaceuticals Inc | -2.063M |